home   /   news   /  James McGuire, Consul of British Consulate General in Shanghai, Visits Zhejiang Orient Gene Biotech Co., LTD
return
James McGuire, Consul of British Consulate General in Shanghai, Visits Zhejiang Orient Gene Biotech Co., LTD
2020-09-21

On September 18, Mr. James McGuire, Consul Life Sciences and Assistant Director, Life Sciences, Health and Social Care, British Consulate General in Shanghai, visited Zhejiang Orient Gene Biotech Co., LTD and made in-depth communication with Mr. Fang Xiaoliang, Chairman of the Company, about the R&D and production of COVID-19 detection reagent and visited the production line of COVID-19 antigen reagent.


图片2.png


Zhejiang Orient Gene Biotech Co., LTD is one of the first companies in China to research and develop COVID-19 antigen reagents. It is the first company to obtain CE certification in China on April 14, and was officially approved to export to the EU in August.

 

Compared with COVID-19 nucleic acid and antibody reagents, antigen reagent has the advantages of rapid, simple and easy extraction, which can be detected by simple nasopharyngeal swab sample extraction on the first day after infection with COVID-19. In addition, during the research and development process, the Company found the most suitable antibody fragments and developed antigens, which were tested in France and the UK and received favorable evaluations. Therefore, since late August, the Company started batch exporting the COVID-19 antigen reagents to countries such as Germany, France, Britain, Italy and Austria.

 

图片3.png


Recently, the Company is expanding its production capacity for COVID-19 antigen reagents to satisfy the demands in Europe and other parts of the world.


Abstract:

On September 18, Mr. James McGuire, Consul Life Sciences and Assistant Director, Life Sciences, Health and Social Care, British Consulate General in Shanghai, visited Zhejiang Orient Gene Biotech Co., LTD and made in-depth communication with Mr. Fang Xiaoliang, Chairman of the Company, about the R&D and production of COVID-19 detection reagent and visited the production line of COVID-19 antigen reagent. (Not necessarily included in the text)